These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27650857)

  • 21. The influence of Flightless I on Toll-like-receptor-mediated inflammation in a murine model of diabetic wound healing.
    Ruzehaji N; Mills SJ; Melville E; Arkell R; Fitridge R; Cowin AJ
    Biomed Res Int; 2013; 2013():389792. PubMed ID: 23555084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of diabetes-related liver injury by the HMGB1/TLR4 inflammatory pathway.
    Jovanović Stojanov S; Martinović V; Bogojević D; Poznanović G; Petrović A; Ivanović-Matić S; Grigorov I
    J Physiol Biochem; 2018 May; 74(2):345-358. PubMed ID: 29611132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detrusor contractility to parasympathetic mediators is differentially altered in the compensated and decompensated states of diabetic bladder dysfunction.
    Klee NS; Moreland RS; Kendig DM
    Am J Physiol Renal Physiol; 2019 Aug; 317(2):F388-F398. PubMed ID: 31141399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy.
    Ma J; Chadban SJ; Zhao CY; Chen X; Kwan T; Panchapakesan U; Pollock CA; Wu H
    PLoS One; 2014; 9(5):e97985. PubMed ID: 24842252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.
    Lin M; Yiu WH; Li RX; Wu HJ; Wong DW; Chan LY; Leung JC; Lai KN; Tang SC
    Kidney Int; 2013 May; 83(5):887-900. PubMed ID: 23423259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toll-like receptor 4 signaling: A common pathway for interactions between prooxidants and extracellular disulfide high mobility group box 1 (HMGB1) protein-coupled activation.
    Zhang Y; Karki R; Igwe OJ
    Biochem Pharmacol; 2015 Nov; 98(1):132-43. PubMed ID: 26367307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity.
    Kim F; Pham M; Luttrell I; Bannerman DD; Tupper J; Thaler J; Hawn TR; Raines EW; Schwartz MW
    Circ Res; 2007 Jun; 100(11):1589-96. PubMed ID: 17478729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant fibrous histiocytoma amplified sequence 1 alleviates inflammation and renal fibrosis in diabetic nephropathy by inhibiting TLR4.
    Lian H; Cheng Y; Wu X
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31696221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Inhibitory Effect of Rapamycin on Toll Like Receptor 4 and Interleukin 17 in the Early Stage of Rat Diabetic Nephropathy.
    Yu R; Bo H; Villani V; Spencer PJ; Fu P
    Kidney Blood Press Res; 2016; 41(1):55-69. PubMed ID: 26849067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toll-like receptor 2 mediates vascular contraction and activates RhoA signaling in vascular smooth muscle cells from STZ-induced type 1 diabetic rats.
    Schmidt L; Carrillo-Sepulveda MA
    Pflugers Arch; 2015 Nov; 467(11):2361-74. PubMed ID: 25600901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TLR4 regulates cardiac lipid accumulation and diabetic heart disease in the nonobese diabetic mouse model of type 1 diabetes.
    Dong B; Qi D; Yang L; Huang Y; Xiao X; Tai N; Wen L; Wong FS
    Am J Physiol Heart Circ Physiol; 2012 Sep; 303(6):H732-42. PubMed ID: 22842069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TLR4 activation mediates kidney ischemia/reperfusion injury.
    Wu H; Chen G; Wyburn KR; Yin J; Bertolino P; Eris JM; Alexander SI; Sharland AF; Chadban SJ
    J Clin Invest; 2007 Oct; 117(10):2847-59. PubMed ID: 17853945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Berberine improves neurogenic contractile response of bladder detrusor muscle in streptozotocin-induced diabetic rats.
    Ren LM; Zhuo YJ; Hao ZS; He HM; Lu HG; Zhao D
    J Ethnopharmacol; 2013 Dec; 150(3):1128-36. PubMed ID: 24184080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of HMGB1 A-box reduced lipopolysaccharide-induced intestinal inflammation via HMGB1/TLR4 signaling in vitro.
    Wang FC; Pei JX; Zhu J; Zhou NJ; Liu DS; Xiong HF; Liu XQ; Lin DJ; Xie Y
    World J Gastroenterol; 2015 Jul; 21(25):7764-76. PubMed ID: 26167076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent.
    Gan LT; Van Rooyen DM; Koina ME; McCuskey RS; Teoh NC; Farrell GC
    J Hepatol; 2014 Dec; 61(6):1376-84. PubMed ID: 25064435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia-induced acute lung injury is aggravated in streptozotocin diabetic mice.
    Wang LM; Zhong NZ; Liu SJ; Zhu XY; Liu YJ
    Exp Lung Res; 2015 Apr; 41(3):146-54. PubMed ID: 25514628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple mechanisms involved in diabetes protection by lipopolysaccharide in non-obese diabetic mice.
    Wang J; Cao H; Wang H; Yin G; Du J; Xia F; Lu J; Xiang M
    Toxicol Appl Pharmacol; 2015 Jun; 285(3):149-58. PubMed ID: 25896969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High mobility group box 1 activates Toll like receptor 4 signaling in hepatic stellate cells.
    Zhang Z; Lin C; Peng L; Ouyang Y; Cao Y; Wang J; Friedman SL; Guo J
    Life Sci; 2012 Sep; 91(5-6):207-12. PubMed ID: 22841886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renoprotective impact of estrogen receptor-α and its splice variants in female mice with type 1 diabetes.
    Irsik DL; Romero-Aleshire MJ; Chavez EM; Fallet RW; Brooks HL; Carmines PK; Lane PH
    Am J Physiol Renal Physiol; 2018 Sep; 315(3):F512-F520. PubMed ID: 29667912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Radix Linderae extracts on a mouse model of diabetic bladder dysfunction in later decompensated phase.
    Yang X; Lian D; Fan P; Xu Y; Wang J; Chen F; Lai H; Jiang W; Zhang L; Huang P; Cao H
    BMC Complement Altern Med; 2019 Feb; 19(1):41. PubMed ID: 30717724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.